Key insight: A large study will test whether matching patients’ genetic variants to known drug responses before they need treatment will improve health and economic outcomes.

Dr. Richard Weinshilboum is asking a big question: What if your doctor knew which drugs to treat you with before you got sick?

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • The problem with pharmacogenomics is that that it is not a perfect predictor. Every patient represents a therapeutic trial with n=1. The best doctors know how to mix and match drugs. If you extend the case for predictive genomics then every doctor would rely on a Watson super computer for the correct drug and dosage. Even if Watson were affordable I know a few doctors that would trust one like Dave trusted HAL in “2001”.

Your daily dose of news in health and medicine

Privacy Policy